• Explore /
  • Poster
  • / Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC).

Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC).

Abstract Poster

Authors

null

Shidong Jia

Genentech, Inc., South San Francisco, CA

Shidong Jia , Sarah Baird , Amanda K. L. Anderson , Shannon L. Werner , Jane Petersen , Ling Huw , Dena C. Marrinucci , Premal H. Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT01485861

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 195)

DOI

10.1200/jco.2016.34.2_suppl.195

Abstract #

195

Poster Bd #

H10

Abstract Disclosures

Similar Posters

First Author: Adam McLain Kase

First Author: Johann S. De Bono

First Author: Andrew J. Armstrong

First Author: Roberta Ferraldeschi